167 related articles for article (PubMed ID: 31922633)
1. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma.
Ke C; Luo JR; Cen ZW; Li Y; Cai HP; Wang J; Chen FR; Siegel ER; Le KN; Winokan JR; Gibson GJ; McSwain AE; Afrasiabi K; Linskey ME; Zhou YX; Chen ZP; Zhou YH
Cancer Sci; 2020 Mar; 111(3):940-950. PubMed ID: 31922633
[TBL] [Abstract][Full Text] [Related]
2. [The anti-cancer effect of ZR30 protein via targeting extracellular signal proteins of different cell subpopulations of glioma].
Li YY; Chen XH; Sun T; Hu Y; Zhou YH; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):812-817. PubMed ID: 30481930
[No Abstract] [Full Text] [Related]
3. Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models.
Li Y; Hu Y; Liu C; Wang Q; Han X; Han Y; Xie XS; Chen XH; Li X; Siegel ER; Afrasiabi K; Linskey ME; Zhou YX; Zhou YH
Oncotarget; 2017 Dec; 8(63):106311-106323. PubMed ID: 29290950
[TBL] [Abstract][Full Text] [Related]
4. Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma.
Nandhu MS; Behera P; Bhaskaran V; Longo SL; Barrera-Arenas LM; Sengupta S; Rodriguez-Gil DJ; Chiocca EA; Viapiano MS
Clin Cancer Res; 2018 Feb; 24(4):821-833. PubMed ID: 29146721
[No Abstract] [Full Text] [Related]
5. EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.
Hu Y; Pioli PD; Siegel E; Zhang Q; Nelson J; Chaturbedi A; Mathews MS; Ro DI; Alkafeef S; Hsu N; Hamamura M; Yu L; Hess KR; Tromberg BJ; Linskey ME; Zhou YH
Mol Cancer; 2011 Sep; 10():123. PubMed ID: 21955618
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
Rong X; Huang B; Qiu S; Li X; He L; Peng Y
Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
[TBL] [Abstract][Full Text] [Related]
8. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
[TBL] [Abstract][Full Text] [Related]
9. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
10. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1.
Chen F; Chen L; He H; Huang W; Zhang R; Li P; Meng Y; Jiang X
Anticancer Agents Med Chem; 2016; 16(5):609-20. PubMed ID: 26373393
[TBL] [Abstract][Full Text] [Related]
12. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
13. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
14. Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells.
Tang NY; Chueh FS; Yu CC; Liao CL; Lin JJ; Hsia TC; Wu KC; Liu HC; Lu KW; Chung JG
Oncol Rep; 2016 Apr; 35(4):2089-96. PubMed ID: 26781422
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
Pen A; Moreno MJ; Martin J; Stanimirovic DB
Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
[TBL] [Abstract][Full Text] [Related]
16. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
[TBL] [Abstract][Full Text] [Related]
17. Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environment.
Hu Y; Ke C; Ru N; Chen Y; Yu L; Siegel ER; Linskey ME; Wang P; Zhou YH
Oncotarget; 2015 Oct; 6(31):30762-72. PubMed ID: 26307682
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device.
Amemiya T; Hata N; Mizoguchi M; Yokokawa R; Kawamura Y; Hatae R; Sangatsuda Y; Kuga D; Fujioka Y; Takigawa K; Akagi Y; Yoshimoto K; Iihara K; Miura T
Mol Biol Rep; 2021 Jan; 48(1):395-403. PubMed ID: 33387197
[TBL] [Abstract][Full Text] [Related]
19. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
Sharma I; Singh A; Siraj F; Saxena S
J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
[TBL] [Abstract][Full Text] [Related]
20. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
